Immunogenicity of COVID-19 vaccines in patients with cirrhosis: Expected advantage for additional dose of vaccine

被引:0
作者
Daungsupawong, Hinpetch [1 ]
Wiwanitkit, Viroj [2 ]
机构
[1] Private Acad Consultant, Phonhong, Laos
[2] Tech Sci Saveetha Univ India, Saveetha Inst Med, Med Coll, Chennai, India
关键词
D O I
10.1080/21645515.2024.2334920
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页数:1
相关论文
共 2 条
[1]   Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis [J].
Ouyang, Lichen ;
Lei, Gang ;
Gong, Yeli .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
[2]   Expected usefulness of the third dose of COVID-19 vaccine for adolescents living with underlying HIV infection [J].
Yasri, Sora ;
Wiwanitkit, Viroj .
INDIAN JOURNAL OF PHARMACOLOGY, 2024, 56 (01) :68-70